These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6278029)

  • 21. Recurrent genital herpes simplex virus infection in guinea pigs.
    Stanberry LR; Kern ER; Richards JT; Overall JC
    Intervirology; 1985; 24(4):226-31. PubMed ID: 3000982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.
    McClements WL; Armstrong ME; Keys RD; Liu MA
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11414-20. PubMed ID: 8876149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genital herpes simplex virus infections].
    Sugase M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():252-5. PubMed ID: 16615477
    [No Abstract]   [Full Text] [Related]  

  • 24. Viral vaccines.
    Kit M; Kit S
    Med Clin North Am; 1983 Sep; 67(5):1129-45. PubMed ID: 6312217
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genital herpes and cervical cancer].
    Posevaia TA; Barinskiĭ IF
    Vopr Virusol; 1983; 28(5):518-30. PubMed ID: 6197814
    [No Abstract]   [Full Text] [Related]  

  • 27. Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses.
    Wu JJ; Huang DB; Tyring SK
    Antiviral Res; 2004 Nov; 64(2):79-83. PubMed ID: 15498602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs.
    Stanberry LR; Bernstein DI; Kit S; Myers MG
    J Infect Dis; 1986 Jun; 153(6):1055-61. PubMed ID: 3009643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women.
    Cone RW; Hobson AC; Brown Z; Ashley R; Berry S; Winter C; Corey L
    JAMA; 1994 Sep; 272(10):792-6. PubMed ID: 8078144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genital herpes: hype or hope?
    Alder MW; Mindel A
    Br Med J (Clin Res Ed); 1983 Jun; 286(6380):1767-8. PubMed ID: 6407556
    [No Abstract]   [Full Text] [Related]  

  • 31. Genital herpes.
    Rand RJ
    Arch Dis Child; 1983 Aug; 58(8):575-6. PubMed ID: 6311114
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrent genital infection in the guinea pig: differences between herpes simplex types 1 and 2.
    Landry ML; Myerson D; Bull C
    Intervirology; 1992; 34(4):169-79. PubMed ID: 1339184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes simplex type 2 infections--an update.
    Marques AR; Straus SE
    Adv Intern Med; 2000; 45():175-208. PubMed ID: 10635049
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic engineering and properties of novel herpes simplex viruses for use as potential vaccines and as vectors of foreign genes.
    Meignier B; Roizman B
    Adv Exp Med Biol; 1989; 257():187-92. PubMed ID: 2559609
    [No Abstract]   [Full Text] [Related]  

  • 36. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine.
    Skinner GR; Fink CG; Cowan M; Buchan A; Fuller A; Hartley CE; Durham J; Wiblin C; Melling J
    Med Microbiol Immunol; 1987; 176(3):161-8. PubMed ID: 3037289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal herpes simplex virus infection: relapse after initial therapy and transmission from a mother with an asymptomatic genital herpes infection and erythema multiforme.
    Brown ZA; Ashley R; Douglas J; Keilly M; Corey L
    Pediatr Infect Dis J; 1987 Nov; 6(11):1057-61. PubMed ID: 2827097
    [No Abstract]   [Full Text] [Related]  

  • 39. The management of pregnancies complicated by genital infections with herpes simplex virus.
    Prober CG; Corey L; Brown ZA; Hensleigh PA; Frenkel LM; Bryson YJ; Whitley RJ; Arvin AM
    Clin Infect Dis; 1992 Dec; 15(6):1031-8. PubMed ID: 1457634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of herpes genitalis.
    Kaufman RH
    J Reprod Med; 1986 May; 31(5 Suppl):379-83. PubMed ID: 3014135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.